Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity.

Source:http://linkedlifedata.com/resource/pubmed/id/17195089

Download in:

View as

General Info

PMID
17195089